We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News   Feb 12, 2018

 
Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Credit: Horizon

FURTHER INFORMATION
 
 
 

Related Product News

OGT Unveils Somatic CNV Detection for CLL with New NGS Panel

Product News

Oxford Gene Technology (OGT), has announced the launch of its SureSeq CLL + CNV Panel — the company’s latest next-generation sequencing offering for research into Chronic Lymphocytic Leukaemia.

READ MORE

Advanced BioMatrix Acquires HyStem® from Lineage Cell Therapeutics

Product News

Advanced BioMatrix has acquired the HyStem® line of products, used for making customizable 3D hydrogels, from Lineage Cell Therapeutics.

READ MORE

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE